254 related articles for article (PubMed ID: 19227011)
21. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.
El-Sayed IH; Huang X; El-Sayed MA
Cancer Lett; 2006 Jul; 239(1):129-35. PubMed ID: 16198049
[TBL] [Abstract][Full Text] [Related]
22. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III.
Fukai J; Nishio K; Itakura T; Koizumi F
Cancer Sci; 2008 Oct; 99(10):2062-9. PubMed ID: 19016767
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency electric field hyperthermia with gold nanostructures: role of particle shape and surface chemistry.
Amini SM; Kharrazi S; Rezayat SM; Gilani K
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1452-1462. PubMed ID: 28891351
[TBL] [Abstract][Full Text] [Related]
25. Non-specific internalization of laser ablated pure gold nanoparticles in pancreatic tumor cell.
Sobhan MA; Sreenivasan VK; Withford MJ; Goldys EM
Colloids Surf B Biointerfaces; 2012 Apr; 92():190-5. PubMed ID: 22192611
[TBL] [Abstract][Full Text] [Related]
26. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM
Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
Tonra JR; Deevi DS; Corcoran E; Li H; Wang S; Carrick FE; Hicklin DJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2197-207. PubMed ID: 16609035
[TBL] [Abstract][Full Text] [Related]
28. Gold-Gold Sulfide nanoparticles intensify thermal effects of radio frequency electromagnetic field.
Sadeghi HR; Toosi MH; Soudmand S; Sadoughi HR; Sazgarnia A
J Exp Ther Oncol; 2014; 10(4):285-91. PubMed ID: 25509984
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles.
Kong T; Zeng J; Wang X; Yang X; Yang J; McQuarrie S; McEwan A; Roa W; Chen J; Xing JZ
Small; 2008 Sep; 4(9):1537-43. PubMed ID: 18712753
[TBL] [Abstract][Full Text] [Related]
30. Peptide-mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes.
Dekiwadia CD; Lawrie AC; Fecondo JV
J Pept Sci; 2012 Aug; 18(8):527-34. PubMed ID: 22764089
[TBL] [Abstract][Full Text] [Related]
31. In situ detection of live cancer cells by using bioprobes based on Au nanoparticles.
Yang J; Eom K; Lim EK; Park J; Kang Y; Yoon DS; Na S; Koh EK; Suh JS; Huh YM; Kwon TY; Haam S
Langmuir; 2008 Nov; 24(21):12112-5. PubMed ID: 18826263
[TBL] [Abstract][Full Text] [Related]
32. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field.
Gannon CJ; Cherukuri P; Yakobson BI; Cognet L; Kanzius JS; Kittrell C; Weisman RB; Pasquali M; Schmidt HK; Smalley RE; Curley SA
Cancer; 2007 Dec; 110(12):2654-65. PubMed ID: 17960610
[TBL] [Abstract][Full Text] [Related]
33. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles.
Li JL; Wang L; Liu XY; Zhang ZP; Guo HC; Liu WM; Tang SH
Cancer Lett; 2009 Feb; 274(2):319-26. PubMed ID: 18977071
[TBL] [Abstract][Full Text] [Related]
34. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer.
Raoof M; Zhu C; Kaluarachchi WD; Curley SA
Int J Hyperthermia; 2012; 28(3):202-9. PubMed ID: 22515341
[TBL] [Abstract][Full Text] [Related]
35. Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.
Reusch U; Sundaram M; Davol PA; Olson SD; Davis JB; Demel K; Nissim J; Rathore R; Liu PY; Lum LG
Clin Cancer Res; 2006 Jan; 12(1):183-90. PubMed ID: 16397041
[TBL] [Abstract][Full Text] [Related]
36. Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab.
Pander J; Heusinkveld M; van der Straaten T; Jordanova ES; Baak-Pablo R; Gelderblom H; Morreau H; van der Burg SH; Guchelaar HJ; van Hall T
Clin Cancer Res; 2011 Sep; 17(17):5668-73. PubMed ID: 21788356
[TBL] [Abstract][Full Text] [Related]
37. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
38. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines.
Kurai J; Chikumi H; Hashimoto K; Yamaguchi K; Yamasaki A; Sako T; Touge H; Makino H; Takata M; Miyata M; Nakamoto M; Burioka N; Shimizu E
Clin Cancer Res; 2007 Mar; 13(5):1552-61. PubMed ID: 17332301
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease.
Bellone S; Frera G; Landolfi G; Romani C; Bandiera E; Tognon G; Roman JJ; Burnett AF; Pecorelli S; Santin AD
Gynecol Oncol; 2007 Sep; 106(3):513-20. PubMed ID: 17540437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
